The site is undergoing maintenance on
Thursday, September 10, 6:00 pm through Friday, September 11, 2:00 am (CEST), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance on
Thursday, September 10, 6:00 pm through Friday, September 11, 2:00 am (CEST), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance on
Thursday, September 10, 6:00 pm through Friday, September 11, 2:00 am (CEST), 2026
.If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of βIL-3 and CD131 expression on Mac-1+ bone marrow cells. BALB/c bone marrow cells (BMC) were stained (20 minutes at 4°C) with PE Rat Anti-Mouse CD131 antibody (1 µg mAb/10^6 cells; Cat. No. 559920) and FITC Rat Anti-Mouse CD11b (Cat. No. 553310). The two-color fluorescence dot plot shows the correlated expression patterns of CD11b versus βIL-3 and CD131 with the forward and side light-scatter characteristics of viable bone marrow cells.
Flow cytometric analysis of βIL-3 and CD131 expression on Mac-1+ bone marrow cells. BALB/c bone marrow cells (BMC) were stained (20 minutes at 4°C) with PE Rat Anti-Mouse CD131 antibody (1 µg mAb/10^6 cells; Cat. No. 559920) and FITC Rat Anti-Mouse CD11b (Cat. No. 553310). The two-color fluorescence dot plot shows the correlated expression patterns of CD11b versus βIL-3 and CD131 with the forward and side light-scatter characteristics of viable bone marrow cells.
Flow cytometric analysis of βIL-3 and CD131 expression on Mac-1+ bone marrow cells. BALB/c bone marrow cells (BMC) were stained (20 minutes at 4°C) with PE Rat Anti-Mouse CD131 antibody (1 µg mAb/10^6 cells; Cat. No. 559920) and FITC Rat Anti-Mouse CD11b (Cat. No. 553310). The two-color fluorescence dot plot shows the correlated expression patterns of CD11b versus βIL-3 and CD131 with the forward and side light-scatter characteristics of viable bone marrow cells.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The JORO50 monoclonal antibody specifically recognizes the extracellular regions of the mouse CD131/βc (Bc, AIC2B, Il3rb1, Csf2rb1) and βIL3 (BIL3, AIC2A, Il3rb2, Csf2rb2) cytokine receptor subunits. A variety of mouse cell types, including multipotential hematopoietic stem cells, mast cells, megakaryocytes, eosinophils, erythroblasts, pre-B cells, and osteoclasts, express βIL-3 and βc subunits. Either βIL-3 or βc can combine with the IL-3Rα chain to form two distinct, functional (i.e., signaling), high affinity receptors for mouse IL-3. The βIL-3 subunit by itself can bind mouse IL-3 with low affinity whereas the βc subunit can not. βc (but not βIL-3) can combine with the IL-5Rα (CD125) and GM-CSFRα (CD116) subunits to form high affinity, signaling receptors for mouse IL-5 or GM-CSF, respectively. The immunogen used to generate the JORO50 hybridoma was the bone marrow-derived, C4-77 pro-T lymphocyte clone.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.